IMO more at play here much more.. 11.5 IMO is just the starting bid. The prospective study will start shortly... with whom I could only imagine somebody with strong credibility especially now that we have a whale on board Pfizer backing us up... this will be the next Catalyst and if the results come through the same as in the pilot clinical trial from 741 patience ( the results will be very similar IMO considering ResApp's screening test was tested alongside the Gold Standard PCR which is near 100% perfect in terms of accuracy already) then I would certainly assume a revised bid. Others may still contend the bid in the meantime as well.. this won't get through as it stands today at 11.5 cents hell I don't even think investors would be happy with 30 or 40 cents as well... ResApp is made up of predominantly retail shareholders and we all know how we all feel a big NO vote at 11.5 cents!
I'm actually contemplating topping up at 11.5, worst case scenario you only lose a little bit of on brokerage. Risk reward ratio is very good.
Cheers
Red bar
Vote NO Pfizer offer, page-206
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #